ScholarWorks@Korea University College of Medicine: Min, Kyung Hoon

Detailed Information

Min, Kyung Hoon (민경훈)

Guro Hospital (Department of Pulmonary, Allergy, and Critical Care Medicine, Guro Hospital)

Research Area: 만성폐쇄성폐질환, 기관지천식, 기관지확장증, Chronic obstructive pulmonary disease, Bronchial asthma, Bronchiectasis

Tel 02-2626-3308
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

COPD:7||Korea:6||Asthma:6||Mortality:6||exacerbation:5||Chronic obstructive pulmonary disease:4||Bronchiectasis:3||acute exacerbation:3||Nonsmall cell lung cancer:3||smoking:3||chronic obstructive pulmonary disease:3||Reactive oxygen species:3||Oxidative stress:3||treatment outcome:3||tuberculosis:3||Bronchoscopy:3||Pulmonary Disease:3||Surgery:3||Chemotherapy:3||Carcinoma:3||Chronic Obstructive:3||Healthcareassociated pneumonia:3||Epidemiology:3||epidemiology:3||Guideline:3||Prognosis:3||ACO:2||asthma:2||lung cancer:2||Biomarker:2||Lung cancer:2||Lung neoplasms:2||mortality:2||chronic obstructive:2||Vascular endothelial growth factor:2||combined pulmonary fibrosis and emphysema:2||comorbidity:2||HealthcareAssociated Pneumonia:2||Pleural effusion:2||prevalence:2||Microbiology:2||Pneumonia:2||Exacerbation:2||Procalcitonin:2||Serum:2||Interstitial:2||Allergic airway disease:2||tobacco smoke:2||Diagnosis:2||virus:2||inflammation:2||General ward:1||Glutathione:1||Hamartoma:1||Heat shock protein:1||HighFlow Nasal Cannula:1||Home oxygen:1||Hospital mortality:1||Hospitalacquired pneumonia:1||Hypoxemia:1||Hypoxia:1||Hypoxiainducible factor1α:1||Ikappa B kinase inhibitor:1||Idiopathic pulmonary fibrosis:1||IgE:1||Immigrants:1||Immunoglobulin G:1||Incidence:1||Inflammation:1||Influenza:1||Influenza Virus:1||Interleukin17:1||Interleukin33:1||KNHANES:1||Kimura disease:1||Koreans:1||Limbic encephalitis:1||Lung Diseases:1||Lung Neoplasms:1||Lung diseases:1||Lung function:1||Lymphangiogenesis:1||Lymphatic metastasis:1||Lymphatic vessels:1||MDA5 protein:1||Mulberry:1||Multiple:1||Nacetyl cysteine proline cysteine amide:1||NonSmallCell Lung:1||Nonsmall cell lung carcinoma:1||Nuclear factorκB:1||Nuclear factorκb:1||Omicron Variant:1||Osteoporosis:1||Oxygen:1||P110δ:1||P38 mitogenactivated protein kinase:1||PI3Kδ:1||Paraneoplastic syndromes:1||Parapneumonic effusion:1||Pelargonium sidoides:1||Phenotype:1||Phosphoinositide 3kinase:1||Physicians' perspective:1||Platinum:1||Pneumococcus:1||Pneumoconiosis:1||Poverty:1||Predictive marker:1||Prescriptions:1||Prevalence:1||Prognostic factor:1||Programmed death ligand 1:1||Prone positioning:1||Pseudomonas aeruginosa:1||Pulmonary Disease, Chronic Obstructive:1||Pulmonary adenocarcinoma:1||Pulmonary cryptococcosis:1||Pulmonary disease:1||Pulmonary edema:1||Pulmonary sarcomatoid carcinoma:1||Quercetin:1||RNA interference:1||Radiofrequency ablation:1||Receptor:1||Reintubation:1||Republic of Korea:1||Respiration:1||Respiration, Artificial:1||Respiratory Distress Syndrome, Adult:1||Respiratory aspiration:1||Respiratory tract infections:1||Resuscitation orders:1||Risk Factors:1||Risk factor:1||Risk factors:1||SARSCoV2:1||Safety:1||Schools:1||Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease:1||Skeletalrelated event:1||Small cell lung cancer:1||Smoking:1||Spirometry:1||Squamous Cell:1||Survey:1||Symptom Flare Up:1||Syndrome:1||Terminal care:1||Therapeutics:1||Thrombophlebitis:1||Thymidylate synthase:1||Tobacco smoke:1||Transglutaminase 2:1||Trauma:1||Treatment Outcome:1||Treatment outcome:1||Tuberculosis:1||Vascular endothelial growth factor A:1||VentilatorAssociated:1||VentilatorAssociated Pneumonia:1||VentilatorInduced Lung Injury:1||Ventilatorassociated event:1||Ventilatorassociated pneumonia:1||Ventilators:1||Viral Identification Rate:1||Virology:1||Viruses:1||Wild type:1||Withholding treatment:1||acute exacerbation of COPD:1||acute respiratory distress syndrome (ARDS):1||adjuvant:1||air pollution:1||air quality index:1||airflow obstruction:1||allergen:1||ambulatory home oxygen:1||artificial:1||bacteria:1||bacterial infection:1||bacterium:1||betalactams:1||biomarker:1||bronchial hyperresponsiveness:1||bronchoscopy:1||cefepime:1||chronic cough:1||chronic obstructive pulmonary disease (COPD):1||club cell secretory protein16:1||combination drug therapy:1||cough:1||ct Mri Etc:1||deterioration:1||drug therapy:1||economics:1||elderly:1||eosinophil:1||epidermal growth factor:1||epidermal growth factor receptor:1||fl uconazole:1||fluoroquinolones:1||food allergy:1||forced expiratory flow between 25% and 75% of vital capacity:1||fungating mass:1||healthcareassociated pneumonia:1||histone deacetylase:1||home oxygen service strategy:1||hypoxiainducible factor 1α:1||imaging:1||immunocompetent host:1||inhaled corticosteroid:1||interleukin (IL)6:1||interleukin27:1||lung injury:1||malignant mesothelioma:1||manifestation:1||mannitol:1||mass screening:1||mechanical:1||medication adherence:1||metabolomics:1||microbial sensitivity tests:1||multiple sites:1||nonsmall cell lung carcinoma:1||nonsmallcell lung:1||obstructive:1||outcome:1||particulate matter:1||physical distancing:1||piperacillin:1||predictors:1||prognostic factors:1||pulmonary disease:1||pulmonary eosinophilia:1||questionnaire:1||readmission:1||reliability:1||respiratory insufficiency:1||risk factors:1||secondline treatment:1||severity:1||single nucleotide polymorphism:1||sirtinol:1||sirtuin 1:1||sleep apnea:1||spirometry:1||tazobactam:1||upper airway cough syndrome:1||urinary Lhistidine:1||validity:1||vascular endothelial growth factor:1||viruses:1||zebrafish:1||Acute Lung Injury:1||Acute bronchitis:1||Acute disease:1||Aged:1||Anaplastic large cell lymphoma:1||AntiBacterial Agents:1||Apoptosis:1||Bacteria:1||Bacterial:1||Bacteriology:1||Biologic markers:1||Biomarkers:1||Biomass smoke:1||Bone Mineral Density:1||Bone metastases:1||Bronchi:1||Bronchial neoplasms:1||COVID19:1||Cannula:1||Cardiac Dysfunction:1||Child:1||Chronic Obstructive Pulmonary Disease:1||Chronic bronchitis:1||Chronic obstructive pulmonary disease (COPD):1||Classification:1||Clinical Outcomes:1||Communityacquired pneumonia:1||Consensus Guideline:1||Cough:1||Cryotherapy:1||DLCO:1||D240:1||DW1601:1||Demography:1||Dihydrocodeine compound:1||Docetaxel:1||Drug Resistance:1||Drug therapy:1||ERCC1:1||Early intervention:1||Economics:1||Eosinophilia:1||Epidermal growth factor receptor:1||Extubation:1||FEV1:1||Firstline chemotherapy:1||Fluoroquinolones:1||Foreign bodies:1||GAP score:1||Gemcitabine:1||

STATISTICS: Total View :13,965,807; Today View :13,755

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE